Werbung
Werbung
OLMA
Olema Pharmaceuticals, Inc. Common Stock
28.08
USDGesponsert
+2.51
+9.83%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
28.18
+0.10
+0.36%
OLMA Ergebnisberichte
Positives Überraschungsverhältnis
OLMA übertreffen die 11 der letzten 20Schätzungen.
55%
Nächster Bericht
Datum des nächsten Berichts
16. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.55
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+12.24%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/+7.84%
Olema Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 10. Nov. 2025, OLMA reported earnings of -0.49 USD per share (EPS) for Q3 25, beating the estimate of -0.49 USD, resulting in a 0.67% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.55 USD, with revenue projected to reach -- USD, implying an increase of 12.24% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Olema Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Olema Pharmaceuticals, Inc. Common Stock reported EPS of -$0.49, beating estimates by 0.67%, and revenue of $0.00, 0% as expectations.
How did the market react to Olema Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.19%, changed from $8.35 before the earnings release to $8.70 the day after.
When is Olema Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 16. März 2026.
What are the forecasts for Olema Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 11
analysts, Olema Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.55 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung